Spark Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Spark Investment Management’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,700	Closed	-$396K	–	135
2020 Q1	$396K	Sell	7,700 -300	-4%	-$16K	0.21%	155
2019 Q4	$494K	Buy	+8,000	New	+$496K	0.06%	350
2019 Q1	–	Sell	-3,900	Closed	-$276K	–	665
2018 Q4	$276K	Sell	3,900 -9,400	-71%	-$721K	0.02%	464
2018 Q3	$1.14M	Buy	+13,300	New	+$1.33M	0.07%	364
2018 Q2	–	Sell	-43,600	Closed	-$3.53M	–	672
2018 Q1	$3.53M	Buy	+43,600	New	+$3.36M	0.23%	141
2017 Q3	–	Sell	-53,100	Closed	-$1.91M	–	735
2017 Q2	$1.91M	Sell	53,100 -98,200	-65%	-$3.14M	0.12%	258
2017 Q1	$4.66M	Sell	151,300 -39,500	-21%	-$1.23M	0.29%	88
2016 Q4	$6.39M	Sell	190,800 -127,700	-40%	-$3.66M	0.53%	33
2016 Q3	$8.47M	Buy	318,500 +25,400	+9%	+$590K	0.69%	14
2016 Q2	$6.46M	Buy	293,100 +220,300	+303%	+$5.77M	0.6%	19
2016 Q1	$2.14M	Buy	+72,800	New	+$2.03M	0.22%	149
2015 Q4	–	Sell	-13,900	Closed	-$502K	–	776
2015 Q3	$502K	Buy	+13,900	New	+$597K	0.07%	375
2014 Q4	–	Sell	-35,800	Closed	-$1.42M	–	725
2014 Q3	$1.42M	Buy	35,800 +22,800	+175%	+$909K	0.21%	155
2014 Q2	$559K	Buy	+13,000	New	+$496K	0.08%	335

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Spark Investment Management's ENTA Position: Q2 2020 in Review

Spark Investment Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2020, closing a stake of 7,700 shares — an estimated $396K sold.

Spark Investment Management first reported a position in ENTA in Q2 2014 and held it in 14 quarters. The position peaked at $8.47M in Q3 2016. 180 funds tracked by Wall St. Rank hold ENTA as of Q2 2020.

Spark Investment Management reported no remaining Enanta Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Spark Investment Management sold 7,700 Enanta Pharmaceuticals shares in Q2 2020, an estimated $396K.
Spark Investment Management first reported a position in Enanta Pharmaceuticals in Q2 2014 and held it in 14 quarters.
Spark Investment Management's Enanta Pharmaceuticals position peaked at $8.47M in Q3 2016.
180 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.